ABSTRACT
At the surrender of Singapore on 15 February 1942, over 100,000 men became prisoners of the Japanese. This included many medical officers who, over the ensuing years, treated men (and some women) suffering the ravaging effects of disease, worsened by the inhumane conditions of captivity. Many medical officers stand out for their work. One in particular, Jacob Markowitz, developed a blood transfusion service, under the most extreme conditions, for the sick working as slave labour on the Burma Railway. Although he qualified 20 years before the outbreak of war, little has been written of Markowitz's early life, or of the impact of this on his war-time contributions.
Subject(s)
Blood Transfusion/history , Military Medicine/history , World War II , Blood Transfusion/methods , History, 20th Century , Myanmar , PrisonersABSTRACT
INTRODUCTION: 'Burning Feet Syndrome' affected up to one third of Far Eastern Prisoners of War in World War 2. Recently discovered medical records, produced by RAF Medical Officer Nowell Peach whilst in captivity, are the first to detail neurological examinations of patients with this condition. METHODS: The 54 sets of case notes produced at the time were analysed using modern diagnostic criteria to determine if the syndrome can be retrospectively classed as neuropathic pain. RESULTS: With a history of severe malnutrition raising the possibility of a peripheral polyneuropathy, and a neuroanatomically plausible pain distribution, this analysis showed that Burning Feet Syndrome can now be described as a 'possible' neuropathic pain syndrome. CONCLUSION: After 70 years, the data painstakingly gathered under the worst of circumstances have proved to be of interest and value in modern diagnostics of neuropathic pain.
Subject(s)
Foot Diseases/history , Neuralgia/history , Prisoners of War/history , Asia, Eastern , Foot Diseases/diagnosis , Foot Diseases/etiology , Foot Diseases/therapy , History, 20th Century , Humans , Malnutrition/complications , Malnutrition/history , Medical Records , Military Medicine/history , Neuralgia/diagnosis , Neuralgia/etiology , Neuralgia/therapy , Physical Examination/methods , SyndromeSubject(s)
Allergy and Immunology/history , Bacteriology/history , England , Germany , History, 20th CenturySubject(s)
Latex Hypersensitivity/immunology , Allergens/immunology , Anaphylaxis/prevention & control , Animals , Child , Child, Preschool , Cross Reactions , Food Hypersensitivity/immunology , Food Hypersensitivity/prevention & control , Fruit/immunology , Humans , Immunotherapy , Infant , Infant, Newborn , Latex Hypersensitivity/diagnosis , Latex Hypersensitivity/prevention & control , Plants/immunology , Pollen/immunology , Risk Factors , Skin Tests , Spinal Dysraphism/diagnosis , Spinal Dysraphism/immunologySubject(s)
Hypersensitivity, Immediate/etiology , Latex/adverse effects , Allergens/immunology , Child , Cross Reactions/immunology , Female , Gloves, Surgical/adverse effects , Health Occupations , Humans , Hypersensitivity, Immediate/immunology , Male , Occupational Diseases/etiology , Plants/immunology , Skin TestsSubject(s)
Allergens/adverse effects , Pollen , Respiratory Hypersensitivity/etiology , Humans , Paris , TreesSubject(s)
Fungi/immunology , Fusarium/immunology , Skin Tests , Cross Reactions , Humans , HypersensitivityABSTRACT
Conjuvac, a new generation of allergen extracts, has been developed to meet the need for improved characterization, purification, and standardization. Conjuvac consists of a dialyzed, standardized aqueous allergen extract chemically conjugated to a sodium alginate carrier and lyophilized in single-dose vials, thus ensuring stability until reconstituted with sterile water just before each injection. A preliminary study of Conjuvac 2 Grass by Pegelow (1984) involving a small number of patients showed this extract to have potential advantages. Accordingly, a study involving more patients was undertaken: two different maintenance dose levels of Conjuvac 2 Grass were investigated and compared to a pyridine-extracted, alum-precipitated two-grass extract called Allpyral, which in previous double-blind trials has been shown to be effective. The trial, which included 125 patients with hay fever and which extended over 2 years, involved ten allergists from seven European countries. Overall, the Conjuvac high-dose regimen proved slightly superior to Allpyral without any increased incidence of side effects, and all treatments stimulated marked increases in specific IgG levels without raising IgE levels.